ATC code P01 Antiprotozoals is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup P01 is part of the anatomical group P Antiparasitic products, insecticides and repellents.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
P01A Agents against amoebiasis and other protozoal diseases
P01AA Hydroxyquinoline derivatives
P01AA01 Broxyquinoline P01AA02 Clioquinol P01AA04 Chlorquinaldol P01AA05 Tilbroquinol P01AA30 Tilbroquinol and tiliquinol P01AA52 Clioquinol, combinationsP01AB Nitroimidazole derivatives
P01AB01 Metronidazole P01AB02 Tinidazole P01AB03 Ornidazole P01AB04 Azanidazole P01AB05 Propenidazole P01AB06 Nimorazole P01AB07 Secnidazole P01AB08 Satranidazole P01AB51 Metronidazole and furazolidone P01AB52 Metronidazole and diloxanide P01AB53 Tinidazole and diloxanideP01AC Dichloroacetamide derivatives
P01AC01 Diloxanide P01AC02 Clefamide P01AC03 Etofamide P01AC04 TeclozanP01AR Arsenic compounds
P01AR01 Arsthinol P01AR02 Difetarsone P01AR03 Glycobiarsol P01AR53 Glycobiarsol, combinationsP01AX Other agents against amoebiasis and other protozoal diseases
P01AX01 Chiniofon P01AX02 Emetine P01AX04 Phanquinone P01AX05 Mepacrine P01AX06 Atovaquone P01AX07 Trimetrexate P01AX08 Tenonitrozole P01AX09 Dehydroemetine P01AX10 Fumagillin P01AX11 Nitazoxanide P01AX52 Emetine, combinationsP01B Antimalarials
P01BA Aminoquinolines
P01BA01 Chloroquine P01BA02 Hydroxychloroquine P01BA03 Primaquine P01BA06 Amodiaquine P01BA07 TafenoquineP01BB Biguanides
P01BB01 Proguanil P01BB02 Cycloguanil embonate P01BB51 Proguanil and atovaquone P01BB52 Chloroquine and proguanilP01BC Methanolquinolines
P01BC01 Quinine P01BC02 MefloquineP01BD Diaminopyrimidines
P01BD01 Pyrimethamine P01BD51 Pyrimethamine, combinationsP01BE Artemisinin and derivatives, plain
P01BE01 Artemisinin P01BE02 Artemether P01BE03 Artesunate P01BE04 Artemotil P01BE05 ArtenimolP01BF Artemisinin and derivatives, combinations
P01BF01 Artemether and lumefantrine P01BF02 Artesunate and mefloquine P01BF03 Artesunate and amodiaquine P01BF04 Artesunate, sulfalene and pyrimethamine P01BF05 Artenimol and piperaquine P01BF06 Artesunate and pyronaridine P01BF07 Artemisinin and piperaquine P01BF08 Artemisinin and naphthoquine P01BF09 Artesunate, sulfadoxine and pyrimethamineP01BX Other antimalarials
P01BX01 Halofantrine P01BX02 Arterolane and piperaquineP01C Agents against leishmaniasis and trypanosomiasis
P01CA Nitroimidazole derivatives
P01CA02 Benznidazole P01CA03 FexinidazoleP01CB Antimony compounds
P01CB01 Meglumine antimonate P01CB02 Sodium stibogluconateP01CC Nitrofuran derivatives
P01CC01 Nifurtimox P01CC02 NitrofuralP01CD Arsenic compounds
P01CD01 Melarsoprol P01CD02 AcetarsolP01CX Other agents against leishmaniasis and trypanosomiasis
P01CX01 Pentamidine isethionate P01CX02 Suramin sodium P01CX03 Eflornithine P01CX04 MiltefosineReferences
"ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020. https://www.nlm.nih.gov/research/umls/sourcereleasedocs/current/ATC/index.html ↩
"Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022. https://www.who.int/tools/atc-ddd-toolkit/atc-classification ↩
"Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022. https://www.whocc.no/atc/structure_and_principles/ ↩
"ATC/DDD Index 2022: code P01". WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atc_ddd_index/?code=P01 ↩